https://aimarketreport.com/ Logo

Biomedical Warming and Thawing Devices Market

Biomedical Warming and Thawing Devices Market Size, Share & Trends Analysis Report

Biomedical Warming and Thawing Devices Market Size, Share & Trend Analysis 2029

Published
Report ID : AIMR 1413
Number of pages : 200
Published Date : May 2023
Category : Life Sciences
Delivery Timeline : 48 hrs

Global Biomedical Warming and Thawing Devices Market is valued at US$ 172.8 Million in 2022 and it is expected to reach US$ 320.0 Million by 2029 with a CAGR of 9.2% over the forecast period.

Global Biomedical Warming and Thawing Devices Market: Global Size, Trends, Competitive, and Historical & Forecast Analysis, 2023-2029- The market will expand due to the increasing advancements in technology, growing biobanking and biotechnology industry, and rising cases of blood-related disorders.

Scope of Global Biomedical Warming and Thawing Devices Market Report-

Biomedical warming and thawing devices are specialized equipment used in the healthcare industry to warm and thaw biological samples, such as blood, tissues, and cells, for various applications. These devices ensure the safe and efficient thawing of frozen samples while maintaining their integrity. Biomedical warming and thawing devices have evolved alongside advancements in medical research and healthcare practices. The development of these devices can be traced back to the need for precise and controlled thawing of biological samples, which has become crucial in fields like blood transfusion, organ transplantation, and research laboratories.

Biomedical warming and thawing devices find applications in various areas, including blood banks, pharmaceutical companies, hospitals, research laboratories, and clinics. They are used for thawing frozen blood and plasma products, cryopreserved cells and tissues, and frozen reproductive materials, among others.

The end-users of biomedical warming and thawing devices include blood banks, hospitals, clinics, research laboratories, pharmaceutical companies, and biotechnology firms. These entities rely on these devices to safely and efficiently thaw frozen biological samples for diagnostic, therapeutic, and research purposes.

Covid-19 Impact on the Global Biomedical Warming and Thawing Devices Market:

The Covid-19 pandemic has had a significant impact on the biomedical warming and thawing devices market. As healthcare systems worldwide focused on managing the pandemic and delivering critical care to Covid-19 patients, the demand for these devices was affected. Non-essential medical procedures and research activities were temporarily halted or significantly reduced, leading to a decline in the overall demand for biomedical warming and thawing devices.

Additionally, the pandemic caused disruptions in the global supply chain, affecting the manufacturing and distribution of these devices. Travel restrictions, lockdown measures, and workforce challenges led to delays in production, shortages of raw materials, and logistical constraints. These factors further contributed to the slowdown in the market growth during the pandemic.

However, there were some areas where the demand for biomedical warming and thawing devices increased due to Covid-19. For instance; these devices were utilized in the storage and processing of blood products and vaccines, which were crucial in the fight against the virus. The development and distribution of Covid-19 vaccines necessitated efficient cold chain management, including proper thawing of frozen vaccines, creating a demand for these devices in specific segments.

Key Players of Global Biomedical Warming and Thawing Devices Market Report-

The global biomedical warming and thawing devices market is driven by several key players, including-

  • Helmer Scientific
  • Boekel Scientific
  • Sartorius AG
  • GE Healthcare
  • Thermo Fisher Scientific Inc.
  • CytoTherm LP
  • Barkey GmbH & Co. KG
  • BioCision LLC
  • Sarstedt AG & Co. KG
  • General Life Biotechnology Co.Ltd.
  • BioCryo
  • BioLife Solutions Inc.
  • Cardinal Health Inc.
  • ThawSTAR
  • Stirling Ultracold
  • TERUMO BCT Inc.
  • Medtronic Plc
  • Barkey GmbH & Co. KG
  • Custom Biogenic Systems
  • Hamilton Medical AG

Market Segmentation

By Product Type:

  • Automatic
  • Manual

By Sample Type:

  • Blood Products
  • Ovum/embryo
  • Semen
  • Others

By Application:

  • Blood Banks and Transfusion Centers
  • Hospitals
  • Research Laboratories and Institutes
  • Pharmaceutical Industry
  • Others

By Regional & Country Level:

  • North America

    • U.S.
    • Canada
  • Europe

    • U.K.
    • France
    • Germany
    • Italy
  • Asia Pacific

    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America

    • Brazil
    • Mexico
  • Middle East and Africa

    • GCC
    • Africa
    • Rest of Middle East and Africa 

Revenue Generation Model:

The revenue generation model for the biomedical warming and thawing devices market typically involves the sale of these devices to end-users. Manufacturers and distributors sell the equipment directly to hospitals, research institutions, and other healthcare facilities. Additionally, they may offer after-sales services, such as maintenance, calibration, and technical support, which can contribute to revenue generation.

Supply Chain Analysis:

The supply chain for biomedical warming and thawing devices market involves various stakeholders, including manufacturers, suppliers, distributors, and end-users. Manufacturers source the necessary components and materials, assemble the devices, and distribute them to distributors or directly to end-users. Suppliers play a crucial role in providing the required raw materials and components to manufacturers. Distributors handle the logistics of delivering the devices to end-users, ensuring efficient distribution and availability.

Value Chain Analysis:

The value chain for biomedical warming and thawing devices market encompasses all the activities involved in bringing the devices to market and delivering value to end-users. This includes research and development, design and manufacturing, sourcing of components, marketing and sales, distribution, installation, training, and after-sales services. Each step in the value chain contributes to the overall value and quality of the devices, ensuring their effectiveness and usability for end-users.

Market Drivers:

The growing biobanking and biotechnology industry: Biobanks store and manage vast collections of biological samples for research and clinical purposes, requiring efficient thawing of frozen samples. Biomedical warming and thawing devices play a crucial role in ensuring the integrity and viability of these samples during the thawing process, thereby supporting the expanding biobanking industry.

For example; as per the news published on January 12th, 2023; BioGrad is to open the UK's second largest biobank facility in Liverpool, as part of a £7.6m investment into a new headquarters at Wavertree Technology Park. In collaboration with the University of Leicester, BioGrad biobank has already welcomed up to 261,000 samples from the largest long-Covid study in the UK. Further partnerships with Liverpool Women’s Hospital and three private research companies will see BioGrad bank over one million human cell samples banked in its first year.

Additionally, the advancements in biotechnology, including genetic research and personalized medicine, rely on the availability of properly thawed samples for accurate analysis and experimentation. The increasing demand for these devices in biobanking and biotechnology sectors is fueling the market growth and driving technological advancements to meet the specific needs of these industries.

Rising cases of blood-related disorders:The rise in the number of blood-related disorders has led to an increase in the demand for blood transfusion centers and the storage of cryopreserved items. This trend is expected to fuel the growth of the biomedical warming and thawing devices market.

According to the Leukemia & Lymphoma Society, it was reported in 2021 that around 186,400 people in the U.S. were expected to be diagnosed with leukemia, accounting for 9.8% of the estimated 1,898,160 new cancer cases in the country. Biomedical warming and thawing devices are also utilized for maintaining cryopreserved samples of ovum, semen, and embryos. The growing prevalence of infertility and the increased number of in-vitro fertilization procedures further contribute to the demand for these devices.

Market Restraints:

High Costs: Biomedical warming and thawing devices can be relatively expensive, especially those equipped with advanced features. The high initial costs associated with these devices can act as a barrier to adoption, particularly for smaller healthcare facilities or research laboratories with budget constraints.

Regulatory Challenges: The biomedical warming and thawing devices market is subject to stringent regulations and standards to ensure patient safety and product quality. Complying with these regulations and obtaining necessary certifications can be time-consuming and costly for manufacturers, potentially hindering market growth.

Market Opportunities:

Increasing adoption of precision medicine: The growing focus on personalized medicine, which requires the use of precise and accurate thawing of biological samples, presents an opportunity for the biomedical warming and thawing devices market. These devices play a crucial role in maintaining sample integrity and viability for personalized treatment approaches.

Advancements in cryopreservation techniques: Technological advancements in cryopreservation techniques, such as vitrification, offer improved preservation and storage of biological samples. The adoption of these techniques increases the demand for specialized biomedical warming and thawing devices that can effectively thaw vitrified samples, presenting opportunities for market growth.

Market Trend Analysis:

Product and Technology Development Trends:

Manufacturers are focusing on developing advanced features such as automated thawing processes, real-time monitoring, and integration with digital systems for data recording and analysis. These innovations enhance the efficiency, accuracy, and user experience of thawing devices.

Customer Trends:

Customers are increasingly seeking user-friendly interfaces, intuitive controls, and improved ergonomics in biomedical warming and thawing devices. Ease of use, reliability, and compatibility with various sample types and sizes are key considerations for customers.

Market Competition Nature:

The market for biomedical warming and thawing devices is competitive, with several key players vying for market share. These companies invest in research and development to introduce innovative products, expand their distribution networks, and enhance their customer support services. Competition is primarily based on factors such as product features, performance, reliability, brand reputation, and pricing.

Strategies by key market players:

Research and Development: Key market players invest in research and development activities to introduce technologically advanced and innovative biomedical warming and thawing devices. This includes improving thawing accuracy, developing automation features, and enhancing overall performance.

Partnerships and Collaborations: Market players often form strategic partnerships or collaborate with research institutions, biobanks, and healthcare facilities to expand their customer base, gain market insights, and enhance product offerings.

Market Expansion: Key players may focus on expanding their market presence by establishing new distribution channels, entering new geographic regions, and targeting emerging markets with high growth potential.

Providing comprehensive after-sales support, including training, technical assistance, and maintenance services, is crucial for market players to build customer loyalty and satisfaction.

Geography Analysis:

North America is a Key Region in the Global Biomedical Warming and Thawing Devices Market:

North America, comprising the United States and Canada, is a prominent market for biomedical warming and thawing devices. The region has a well-established healthcare infrastructure, advanced research facilities, and a high prevalence of chronic diseases, all contributing to the demand for these devices.

Key factors driving the market in North America include the rising number of blood-related disorders, increasing adoption of precision medicine, and the presence of leading healthcare and research institutions. The region also has a mature biobanking industry and a robust biotechnology sector, further supporting the demand for biomedical warming and thawing devices. For example; the U.S. Centers for Disease Control and Prevention estimates about 3 million people in the U.S. have some type of anemia. And, Sickle cell disease affects 90,000 to 100,000 people in the U.S. About 1,000 babies are born with the disease each year.

Moreover, North America is characterized by a strong focus on technological advancements and innovations. Companies in the region invest heavily in research and development activities to introduce advanced features and technologies in biomedical warming and thawing devices. This leads to a competitive market landscape and a constant influx of new products with enhanced capabilities.

Europe is Leading the Way in Biomedical Warming and Thawing Devices Industry with Advancing Healthcare Innovation:

In Europe, there is a strong emphasis on biobanking and genetic research, which drives the demand for biomedical warming and thawing devices. The region is home to several leading biobanks and research institutions that require efficient and reliable thawing solutions for their cryopreserved samples.

European countries also have stringent regulations and quality standards in place for the storage and handling of biological samples, including blood products and reproductive materials. This regulatory environment creates a favorable market landscape for biomedical warming and thawing devices, as compliance with these standards is crucial.

Additionally, Europe has a high prevalence of blood-related disorders and a growing demand for blood transfusion centers. This further contributes to the demand for biomedical warming and thawing devices in the region.

Key Benefits of Global Biomedical Warming and Thawing Devices Market Report–

  • Global Biomedical Warming and Thawing Devices Market report covers in-depth historical and forecast analysis.
  • Global Biomedical Warming and Thawing Devices Market research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, and Regional and Country Level.
  • Global Biomedical Warming and Thawing Devices Market report helps to identify opportunities in the marketplace.
  • Global Biomedical Warming and Thawing Devices Market report covers extensive analysis of emerging trends and competitive landscape.
SUMMARY
VishalSawant
Vishal Sawant
Business Development
vishal@brandessenceresearch.com
+91 8830 254 358
Segmentation
Segments

By Product Type:

  • Automatic
  • Manual

By Sample Type:

  • Blood Products
  • Ovum/embryo
  • Semen
  • Others

By Application:

  • Blood Banks and Transfusion Centers
  • Hospitals
  • Research Laboratories and Institutes
  • Pharmaceutical Industry
  • Others
Country
Regions and Country

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Sweden
  • Netherlands
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe

Asia-Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest of APAC

Latin America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of South America

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of MEA
Company
Key Players
  • Helmer Scientific
  • Boekel Scientific
  • Sartorius AG
  • GE Healthcare
  • Thermo Fisher Scientific Inc.
  • CytoTherm LP
  • Barkey GmbH & Co. KG
  • BioCision LLC
  • Sarstedt AG & Co. KG
  • General Life Biotechnology Co.Ltd.
  • BioCryo
  • BioLife Solutions Inc.
  • Cardinal Health Inc.
  • ThawSTAR
  • Stirling Ultracold
  • TERUMO BCT Inc.
  • Medtronic Plc
  • Barkey GmbH & Co. KG
  • Custom Biogenic Systems
  • Hamilton Medical AG

+44-1173181773

sales@brandessenceresearch.com

We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com

JOIN US

LONDON OFFICE

AI® Market Research and Consulting Pvt ltd.

124, City Road, London EC1V 2NX

FOLLOW US

Twitter
Facebook
LinkedIn
Skype
YouTube

CONTACT US

1-888-853-7040 - U.S. (TOLL FREE)+44-1173181773 - U.K. OFFICE+91-7447409162 - INDIA OFFICE

© Copyright 2025-26 AI® Market Research and Consulting. All Rights Reserved | Designed by AI® Market

PaymentModes